Anthony Johnson

Company: Goldfinch Bio
Job title: President & Chief Executive Officer
Seminars:
Panel Discussion: Challenges & Opportunities in Drug Development for Rare Kidney Diseases 4:00 pm
Precision medicine in rare kidney disease drug development Strategies in selecting endpoints for regulatory approval Partnering with patient advocacy groups and registriesRead more
day: Day One
Leveraging a Precision Medicine Approach to Inform Future Directions of Drug Development in CKD 11:30 am
Reflecting on recent progress: what has been achieved so far? Applying lessons in biomarkers and clinical trial innovation to CKD drug development Looking to the future: paving the way for pipeline progression and new therapiesRead more
day: Track 2 - Day 1 AM